BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 21224540)

  • 1. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer.
    Torisu M; Hayashi Y; Ishimitsu T; Fujimura T; Iwasaki K; Katano M; Yamamoto H; Kimura Y; Takesue M; Kondo M
    Cancer Immunol Immunother; 1990; 31(5):261-8. PubMed ID: 2198088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide.
    Kato M; Hirose K; Hakozaki M; Ohno M; Saito Y; Izutani R; Noguchi J; Hori Y; Okumoto S; Kuroda D
    Cancer Immunol Immunother; 1995 Mar; 40(3):152-6. PubMed ID: 7728773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer.
    Oba K; Teramukai S; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
    Cancer Immunol Immunother; 2007 Jun; 56(6):905-11. PubMed ID: 17106715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®)): review of development and future perspectives.
    Maehara Y; Tsujitani S; Saeki H; Oki E; Yoshinaga K; Emi Y; Morita M; Kohnoe S; Kakeji Y; Yano T; Baba H
    Surg Today; 2012 Jan; 42(1):8-28. PubMed ID: 22139128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An indicator quantitatively comparing two treatment effect sizes on responder and non-responder groups--exponential of estimated interaction parameter.
    Sugita M; Izuno T; Kanamori M; Ogoshi K; Mitomi T
    Cancer Immunol Immunother; 1995 Oct; 41(4):251-6. PubMed ID: 7489568
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Habtemariam S
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32466253
    [No Abstract]   [Full Text] [Related]  

  • 7. Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review.
    Fritz H; Kennedy DA; Ishii M; Fergusson D; Fernandes R; Cooley K; Seely D
    Integr Cancer Ther; 2015 May; 14(3):201-11. PubMed ID: 25784670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
    Fisher M; Yang LX
    Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of PSK on recurrence of stage II/III gastric cancer].
    Tanaka H; Muguruma K; Kubo N; Amano R; Noda E; Yamada N; Yashiro M; Maeda K; Sawada T; Ohira M; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2258-60. PubMed ID: 21224540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
    Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
    Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of polysaccharide K (PSK) for stage III rectal cancer in clinical practice].
    Ishibashi K; Hokama N; Ishiguro T; Kuwabara K; Okada N; Ohsawa T; Miyazaki T; Yokoyama M; Ishida H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1975-8. PubMed ID: 20037296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
    Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
    Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-bound polysaccharide K partially prevents apoptosis of circulating T cells induced by anti-cancer drug S-1 in patients with gastric cancer.
    Kono K; Kawaguchi Y; Mizukami Y; Mimura K; Sugai H; Akaike H; Fujii H
    Oncology; 2008; 74(3-4):143-9. PubMed ID: 18708731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer].
    Mitomi T; Kyoji-Ogoshi
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2532-7. PubMed ID: 3090939
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.